Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study

Tetsuya Shindo,Kohei Hashimoto,Takashi Shimizu,Naoki Itoh,Naoya Masumori

Significance of intraprostatic architecture and regrowth velocity for considering discontinuation of dutasteride after combination therapy with an alpha blocker: A prospective, pilot study

2015

Tetsuya Shindo
Kohei Hashimoto
Takashi Shimizu
Naoki Itoh
Naoya Masumori

Purpose We conducted a prospective single-center study to evaluate the possibility of discontinuation of dutasteride after combination therapy with an alpha blocker for benign prostatic hyperplasia (BPH).

Keywords:

Alpha blocker
Prostate-specific antigen
Prospective cohort study
Discontinuation
Urology
5 Alpha-Reductase Inhibitor
Dutasteride
Prostate
Combination therapy
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations